In this meta-analysis on correlation between schizophrenia and breast cancer (BC), we found that the incidence of schizophrenia is positively correlated with BC, and the incidence of BC in schizophrenia patients is increased in a certain degree. Because of the effects of potential bias and publication bias, the conclusion needs more high-quality studies to increase the strength of evidence. Purpose: To determine the correlation between schizophrenia and breast cancer (BC). Methods: We searched relevant articles indexed in the PubMed, Embase, and Cochrane Library databases; managed the data in Endnote X7 software; evaluated literature quality by Newcastle-Ottawa quality evaluation criteria; designed tables; and extracted relevant data. The main outcome measure was BC incidence. Effect values were risk ratio and 95% confidence intervals. We used Stata 13.1 software to perform the meta-analysis, choosing a corresponding combination model according to heterogeneity test results and carrying out subgroup analyses in order to better understand the stability of results through sensitivity analysis. Results: On the basis of 15 studies that assessed patients in different geographic regions, meta-analysis results showed that BC incidence between the exposure group (patients with schizophrenia) and the control group (nonschizophrenia population or general population) had statistical difference (risk ratio ¼ 1.18; 95% confidence interval, 1.05, 1.32), thus showing that BC incidence in patients with schizophrenia is higher than in the nonschizophrenia or general population. Subgroup analysis indicated that gender and geographic region may be sources of the assessed studies' heterogeneity. Conclusion: The incidence of schizophrenia is positively correlated with BC, and the incidence of BC in patients with schizophrenia is increased to a certain degree. Because of the effects of potential and publication bias, this conclusion needs more high-quality studies to increase the strength of evidence.
Introduction
The health status of psychiatric patients has attracted more and more attention in the past decade; approximately 85% excess mortality is related to natural reasons, and approximately 15% mortality is related to suicide and other nonnatural reasons. 1 So far, most studies on the mortality risk of psychiatric patients have focused on the risk factors of cardiovascular disease but ignore other reasons, such as cancer. Most studies indicate that the heart metabolic rate of psychiatric patients is increased and that the incidence and mortality of cardiovascular diseases are increased significantly. However, there is no consensus on the relationship between mental illness and cancer. Some studies have pointed out that mental illness increases the incidence of cancer. [2] [3] [4] Other studies note that mental illness does not increase [5] [6] [7] [8] or may even decrease 9 the incidence of cancer. Those differences may be caused by different manifestations of mental illness or by different types of cancer. For example, Huntington chorea is a kind of mental illness; the risk of such patients having digestive tract cancer is lower than that of general population. 10, 11 In mental illness, patients with schizophrenia have a lower incidence of prostate cancer and melanoma but are at high risk of breast cancer (BC).
unknown. More and more clinical studies and epidemiologic studies have pointed out that prolactin (PRL) plays a relatively important role in the occurrence and development of BC. In the 1990s, a study constructed transgenic mice overexpressing human growth hormone, including PRL, which can activate the PRL receptor to induce mice to develop BC. 15 Another study showed that the expression level of PRL in human BC cells is higher than that of normal breast tissue. 16 PRL combines with PRL receptor to stimulate the downstream signal pathway, resulting in relevant biological changes of breast epithelial cells, including the promotion of apoptosis and vascularization, as well as the enhancement of tumorcell proliferation and migration. 17, 18 The process of carcinogenesis of the mammary glands is the same as that of normal breast tissue, which is mainly a process of hormone dependence. Estrogen, progesterone, and even PRL play an important role in the growth and differentiation of mammary gland cells. 17, 19 Many antipsychotic drugs can increase serum PRL levels, especially first-generation antipsychotic drugs. 20, 21 The plasma concentration of PRL has been found to be significantly increased in 80% to 90% of female subjects. 22 Compared to first-generation antipsychotic drugs, the effect of second-generation antipsychotic drugs' (in addition to risperidone and amisulpride) increasing the plasma PRL level is weak. The purpose of this study was to explore the correlation between schizophrenia and BC. Meta-analysis can combine and analyze different study results, find key points of dispute through heterogeneity tests and sensitivity analyses, and thereby obtain more abundant information than that presented in the original literature.
Materials and Methods

Inclusion Criteria
To be considered for inclusion in the meta-analysis, the studies had to fulfill the following criteria. The object of the study had to include patients previously diagnosed as having schizophrenia, excluding other mental illness; age and sex were not limited. For intervention measures, the patients in the exposed group had to be patients with schizophrenia, and the control group had to comprise patients without schizophrenia or the general population. For the study outcome, the primary outcome index had to be incidence of BC, and the correlation indexes of schizophrenia and BC had to be risk ratio (RR), odds ratio (OR), standardized incidence ratio (SIR), or hazard ratio (HR). Study types included retrospective or prospective studies published in Chinese or English.
Exclusion Criteria
Studies were excluded for the following reasons: studies had no clear criteria provided for diagnosis and no clear standard of inclusion and exclusion; the studies of outcome measures were of mortality (ie, standardized mortality rate); the studies reported data that were obviously incorrect or incomplete, or were unable to provide the outcome; and the study had been published before.
Retrieval Strategy
We searched authoritative databases, including PubMed, Embase, and the Cochrane Library, for relevant literature published through March 2016. We used the following retrieval terms: breast neoplasm, breast tumor, breast cancer, schizophrenia, schizophrenias, schizophrenic disorders, psychosis.
Literature Screening Method
We introduced our bibliography into Endnote X7 software to check each study. Only literature that met the inclusion criteria was adopted. Subsequently, literature that met the exclusion criteria was excluded. After a preliminary screening, the included studies were read carefully to confirm that they had complete information for data consolidation.
Evaluation of Literature Quality
Internalization studies were carried out via quality evaluation according to the Newcastle-Ottawa quality evaluation standard (NOS). NOS uses the semiquantitative principle of a star system to evaluate literature quality; the best score is 9 stars. 23 The minimum follow-up time of the exposure group was set for 8 years, according to incidence characteristics of BC. 14 
Data Extraction
We designed a data extraction form. Extraction contents included the internalization study's first author, year of publication, geographic area of study, study object and design, population of exposure and control groups, expected outcome, number of subjects in the exposure and control groups, effect indexes, and correction factors of effect indexes.
All processes of literature screening, quality evaluation, and data extraction were carried out by two evaluators. Disagreement was resolved by discussion or by assistance from a third researcher.
Indexes of Primary Outcome
We created a correlation index of schizophrenia and BC, RR, OR, HR, and SIR, as well as the corresponding confidence interval (CI), including upper and lower limits. SIR refers to the ratio between exposure population incidence and expected incidence. RR refers to the ratio of risk between the exposure group (measure index is cumulative incidence or incidence density) and the control group. The implication of OR is similar to RR, which means how many times the risk between exposure group and nonexposure group. HR refers to the ratio of risk function between the exposure population and the control population; although this is similar to RR, HR includes time factor-in other words, HR is RR including a time effect.
Statistical Analysis
Statistical analysis was conducted by Stata 13.1 software (StataCorp, College Station, TX). The primary outcomes of interest for our study were the indicators associated with schizophrenia and BC, which was calculated as RR, OR, HR, and SIR with their corresponding 95% CIs, including upper and lower limits. Because the absolute risk of BC or schizophrenia is low, the 4 measures of association are expected to yield similar estimates of RR. Consequently, we presented all RR estimates pooled together, as appropriate, so that comprehensiveness of analysis and maximization of statistical power were ensured. We assumed that the logarithm of RR was normally distributed. The particular asymptotic error would not affect the statistical result. Summary RRs with 95% CIs were calculated with the method of DerSimonian and Laird by use of the assumptions of a random-effects model, which considers Clinical Breast Cancer February 2019 -e173 both within-study and between-study variation. [24] [25] [26] Results are shown as subgroup analyses by reference population (sex and geographic area) and literature quality. 
Results
Literature Retrieval and Screening
Search results are provided in Figure 1 . A total of 847 articles were potentially relevant according to our initial search terms; 112 of them were excluded because they were duplicated. In strict accordance with our inclusion and exclusion criteria, we excluded another 720 studies of the remaining 735. A total of 15 studies published between 2001 and 2013 were finally included in the present meta-analysis.
3-5,26-37
Literature Quality and Publication Bias
We evaluated literature inclusion by NOS. The quality score of the included 15 articles was 5 to 8 stars. There was no evidence of funnel plot asymmetry or Egger test results significant for publication bias ( Figure 2 ). We therefore believe that there was no publication bias (P ¼ .555).
Internalization Literature
The data provided by the various studies included in our metaanalysis are shown in Table 1 . These data mainly included year, geographic area, study design, object selection, follow-up time, characteristics of exposure and control populations, main effect index, correction factors of the effect index, and confounding factors of the exposure and control groups. All internalization studies were of retrospective design. The geographic areas mainly included Europe, Asia, Oceania, and North America, including 7 articles in Europe (including Finland, Denmark, Sweden, and the United Kingdom), 3 
Correlation Between Schizophrenia and BC
The 15 internalization articles described exposure groups that included patients with schizophrenia, and control groups that included patients without schizophrenia or a general population living in the same area as the exposure group. Based on metaanalysis, the studies have statistical heterogeneity (P < .001, I
2 ¼ 88.6%). We chose a random-effects model to combine them. Results show that BC incidence between the exposure and control groups differs (RR ¼ 1.18; 95% CI, 1.05, 1.32). Our data suggest that patients with schizophrenia are significantly associated with a higher risk of BC compared to those without schizophrenia ( Figure 3) . The morbidity rate of BC is relevant to sex: it mostly happens in female subjects. For this reason, for effect-size merging, we selected studies that assessed women, thereby excluding two studies. 30, 32 Meta-analysis revealed that statistical heterogeneity occurred among each research group (P < .001, I
2 ¼ 89.9%), so we selected the random-effects model for merging. The subgroup analysis was carried out on patients according to sex. Thirteen articles addressed female patients. The RR value after combination was 1.18 (95% CI, 1.04, 1.33). The morbidity rate of female BC patients with or without schizophrenia had statistical significance (RR ¼ 1.18; 95% CI, 1.04, 1.33; P ¼ .013). Indeed, schizophrenia can be regarded as a dangerous BC morbidity factor among women. Three articles included male patients. The RR value after combination was 1.64 (95% CI, 0.86, 3.13). The different morbidity of the male patients with or without schizophrenia did not have statistical significance (RR ¼ 1.64; 95% CI, 0.86, 3.13; P ¼ .259). It showed that schizophrenia could not be regarded as a dangerous BC morbidity factor among male subjects (Figure 4 ). The subgroup analysis results therefore indicate that sex may be one of the sources of study heterogeneity.
The study object was the population in different geographic areas and comprising different races, according to areas for which subgroup analysis could be performed. Seven articles described European populations (including Finland, Denmark, Sweden, and the United Kingdom) 3 ; based on meta-analysis, the studies had statistical heterogeneity (P < .001, I
2 ¼ 93.3%). A random-effects model was chosen to combine these studies. Results found that incidence of BC between the exposure and control groups had no statistical significance (RR ¼ 1.07; 95% CI, 0.85, 1.35; Figure 4 ). Groups from different geographic regions and of different races were regarded as objects of research, and subgroup analysis was implemented according to region. Europeans were involved in 7 articles (including Finland, Denmark, Sweden, and the United Kingdom) 3, 21, 27, 29, 30, 32, 36 ; meta-analysis revealed that there was no statistical heterogeneity among research groups (P ¼ .064, I 2 ¼ according to different geographic regions, and the random-effects model was selected for combination. The RR value after combination was 1.16 (95% CI, 1.06, 1.28). In Europe, the different morbidity rate of the BC of the patients with or without schizophrenia had statistical significance (P ¼ .001). This indicates that schizophrenia could be regarded as a dangerous morbidity factor of BC among Europeans. In Asia, there were 6 related literature reports (including Israel and Taiwan) 28, 31, [33] [34] [35] 37 ; meta-analysis showed that there was statistical heterogeneity among research groups (P < .001, I
49.7%). The subgroup analysis was carried out on patients
2 ¼ 93.3% Figure 5 ). Schizophrenia therefore ought not be regarded as a dangerous morbidity factor of BC.
On the basis of the geographic region subgroup analysis results, region may be a source of article heterogeneity. Table 2 presents subanalyses by quality of literature within the subgroup of study quality score as evaluated by NOS. The quality scores of the 15 articles included in this meta-analysis ranged from 5 to 8 stars, divided into 3 groups. Four studies had a score of 8 21, [32] [33] [34] [35] ; 5 studies had a score of 7 4, 5, 29, 30, 37 ; and 6 studies had a score of < 7. 3, 27, 28, 31, 33, 36 Meta-analysis showed no significant differences in the incidence of BC among research groups when the quality score was equal to 8 and less than 7 (respectively, RR ¼ 1.10; 95% CI, 0.97, 1.26; and RR ¼ 1.09; 95% CI, 0.76, 1.58), while we found significant differences in the incidence of BC among research groups (RR ¼ 1.36; 95% CI, 1.06, 1.75) when the quality score was equal to 7 ( Figure 6 ).
In short, sex, geographic region, and literature quality may be sources of article heterogeneity. 
Discussion
Results of Correlation Analysis
At present, there is no consensus on BC incidence in patients with schizophrenia. Indeed, the results of the studies included in this meta-analysis are not consistent. In the 15 articles included in this meta-analysis, several studies showed that the risk of patients with schizophrenia having BC is higher than the general population, 4, 28, 29, 32, [35] [36] [37] but others found that the risk of patients with schizophrenia having BC is decreased. 31, 33 Other studies, however,
show that there is no correlation between schizophrenia and BC. [3] [4] [5] 29, 33, 35 When we combined and comprehensively analyzed the articles, we found that the incidence of BC between the exposure and control groups was different (RR ¼ 1.18; 95% CI, 1.05, 1.32), thereby indicating that the risk of patients with schizophrenia having BC is higher than that of patients without schizophrenia or the general population.
There are many reasons for BC, including obesity. One metaanalysis that included 282,000 subjects showed that the risk of having BC is increased with an increase in body mass index (BMI). The risk of people with BMI > 30 kg/m 2 having BC is 1.3 to 2 times that of people of normal weight, and obesity can significantly increase the risk of women having BC. 38 In particular, the incidence of BC in postmenopausal women is positively correlated with body weight and BMI. 39 Obesity promotes biosynthesis of estrogen, and estrogen binding globulin level is decreased. BC is hormone dependent, and excessive serum estrogen will cause abnormal proliferation and transformation of BC cells. 40 Adiponectin and leptin secreted by adipose tissue may mediate the process of obesity, promoting occurrence and development of BC. In addition, obesity can lead to the occurrence of chronic inflammation; a large number of inflammatory factors and various cells in the body can form a tumor microenvironment that promotes the occurrence and 
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Clinical Breast Cancer February 2019 -e181 41 Patients with schizophrenia have a high incidence of obesity as a result of uncontrolled diet, lack of exercise, and receipt of antipsychotic drugs, among other factors. 42 Diabetes, which may be related to obesity and antipsychotic drugs, is also a nonindependent risk factor of patients with schizophrenia having BC. Patients with schizophrenia often have symptoms of type 2 diabetes. Forty percent of patients with schizophrenia have a family history of type 2 diabetes, and indeed the incidence of patients with schizophrenia having type 2 diabetes is significantly higher than that of general population. 43, 44 Many studies show that the incidence of patients with diabetes having BC is higher than that of general population, and the mortality rate is also higher than that of general population. 45 At present, early screening is one of the most effective methods to prevent BC; however, regular and formal screening is difficult to achieve for patients with schizophrenia. A study by Jensen et al 46 on the participation rate of BC screening in women with schizophrenia found that it is common for them to never or rarely participate in BC screening. Hyperprolactinemia is considered to be one of main reasons why patients with schizophrenia are at a high risk of BC. Prolactin is a protein hormone secreted by anterior pituitary and is an important neuroendocrine factor; it also plays an important role in the growth and differentiation of mammary gland cells. 21 Büschlen et al 47 and
Druyts et al 48 found that there are pathologic changes in the hypothalamusepituitaryegonadal axis of patients with schizophrenia; the inhibition function of dopamine is decreased and serum PRL level is increased. Antipsychotic drugs may also cause an increase in serum PRL. Drugs that result in a high frequency of hyperprolactinemia are chlorpromazine and risperidone; ziprasidone and aripiprazole have no significant effect on female PRL. 49 At present, there is enough evidence to show that hyperprolactinemia is Figure 6 Forest Plots for Random-Effects Meta-analysis of Breast Cancer Incidence Rates by Newcastle-Ottawa Quality Evaluation Standard Score
Clinical Breast Cancer February 2019 -e183 related to an increasing risk of BC. 50 Studies show that childbirth and lactation are protective factors of BC, which are mainly related to hormone (mainly estrogen and progesterone) level changes during pregnancy and lactation. 51 Fewer female patients with schizophrenia establish a family than women in the general population. In addition, regarding lactation, in the past, clinicians did not recommend that patients with schizophrenia breast-feed. An unhealthy lifestyle is a high risk factor for BC. For example, patients with schizophrenia tend to smoke; indeed, one study found that smoking increases the risk of BC incidence. 52 The mechanism may be that some substances in tobacco smoke have a direct or indirect reversible or irreversible effect on the occurrence and development of BC. 53 Many patients with schizophrenia engage in substance abuse, especially alcohol abuse. 54 Epidemiologic studies
show that drinking alcoholic beverages can increase the risk of BC. In addition, some experimental studies have confirmed that drinking can promote the growth and metastasis of existing tumors. [55] [56] [57] As a result of the sedative effect, a relatively closed living environment, behavioral withdrawal, partial loss of life skills, and lack of activity, among other reasons, patients with schizophrenia lack adequate exercise. A relatively sedentary lifestyle is one of the risk factors of BC. Ligibel et al 58 found that exercise is a protective factor for metastasis and prognosis of early BC.
Outcome Bias
This meta-analysis quantitatively analyzed the study data of 15 studies. All the studies included study subjects from crowd-based population or medical registries. The outcome of follow-up study is incidence, which avoids the confounding effect of mortality on study results. Some patients with cancer died from other diseases, such as cardiovascular disease or respiratory failure, which may be related on a medical level. As Figure 2 indicates, a large heterogeneity exists among the included studies. In particular, 2 articles about patients in Israel showed that schizophrenia is a protective factor of BC. 31, 33 This may be related to different methods of patient inclusion. Both articles studied patients with schizophrenia registered in the online system of the Abarbane Mental Health Center; these patients received regular and systematic treatment. The exposure group included hospitalized patients with schizophrenia; risk factors of BC such as obesity, diabetes, smoking, and alcohol abuse were effectively controlled for. The control group was the general population. Therefore, we can ascertain that the cancer incidence of the exposure group is lower than that of control group, which shows that cancer incidence in patients with schizophrenia is higher than that of the general population, and which may be caused by environmental rather than genetic factors. The incidence of cancer (such as BC) can be decreased as long as effective 3-level prevention disease management can be provided to patients with schizophrenia.
Overall, the quality of internalization study evidence was high. The main problem was that in the included literature, only 4 studies had a median follow-up period of > 8 years. 4, 30, 34, 35 The rest had follow-up periods of < 8 years or the period was not mentioned. Too short a follow-up time will cause the expected outcome measure of the object to be incompletely observed, resulting in a lower than actual incidence rate. Two articles excluded cancer cases in the first year of follow-up, 29,33 2 articles excluded cancer cases in the first 6 months before follow-up, 21, 37 and the other articles did not mention whether cancer cases were excluded. We therefore still cannot determine whether the object of study had an expected outcome in the initial study. In the comparison process of patients with schizophrenia with patients without schizophrenia or the general population, we found that the most important confounding factor was other mental illness or receipt of antipsychotic drugs. In addition, sex, age, and follow-up time were also important confounding factors. McGinty et al 4 studied but did not control for confounding factors, so they could not ensure the comparability of their exposure and control groups. Such problems as these lead to bias and affect the authenticity of the results. In summary, schizophrenia is positively correlated with BC incidence, and BC incidence of patients with schizophrenia is increased to a certain degree. Because of the effects of potential bias and publication bias, this conclusion still requires more high-quality studies to increase the strength of evidence.
Clinical Practice Points
We performed a meta-analysis to explore the correlation between schizophrenia and BC. Meta-analysis can combine and analyze different study results, find the key point of dispute through heterogeneity test and sensitivity analysis, and obtain more abundant information than the original literature. On the basis of 15 studies performed in different regions, metaanalysis revealed that BC incidence between the exposure group (schizophrenia patients) and the control group (nonschizophrenia population or general population) had statistical difference, thus indicating that BC incidence in schizophrenia patients is higher than that of the nonschizophrenia population or general population. Subgroup analysis indicated that gender and region may a source of article heterogeneity. The incidence of schizophrenia is positively correlated with BC, and the incidence of BC in schizophrenia patients is increased to a certain degree. Because of the effects of potential bias and publication bias, this conclusion needs more high-quality studies to increase the strength of evidence.
